ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up

1. Valverde-Megías, A.
2. Veganzones-de-Castro, S.
3. Donate-López, J.
4. Maestro-de-las-Casas, M.L.
5. Megías-Fresno, A.
6. García-Feijoo, J.